TABLE 1.
Reference | Study population | N | Clinical Definition of Treatment Failure | Failure |
---|---|---|---|---|
Shann et al. 1985(29) |
Ages not stated; Papua New Guinea; Inpatients; Severe pneumonia | 748 | At any point: Change of antibiotic treatment; Death | 15.9% |
Strauss et al. 1998(30) |
2–59 months; Pakistan; Outpatient and inpatient; Non-severe and severe pneumonia | 595 | At 48 hours, any of: Resting SaO2 ≤ 87%; tachypnoea; any danger sign; No improvement or deterioration in the opinion of a senior clinician | 20.5% |
Duke et al. 2002(31) |
1-59 months; Papua New Guinea; Inpatient; Very severe pneumonia | 1116 | At 5 days, any 4 of: Fever, Tachypnoea/apnoeas, chest wall indrawing, crepitations, bronchial breathing, low oxygen sats; Death ; Readmission within 1 month | 18.6% |
Addo-Yobo et al. 2004(14) |
3–59 month; International; Inpatient; Severe pneumonia | 1702 | At 48 hours, any 1 of: Danger signs, low SaO2, persistent indrawing, serious adverse drug reaction, new antibiotic, new comorbidity, abscondment, death | 19% |
McNally et al. 2007(5) |
1-59 months; South Africa; Inpatient; Severe and very severe pneumonia | 358 | At 48 hours, persistence or worsening of any 1 of: heart rate, respiratory rate, temperature, inability to drink, increased oxygen requirements; New danger signs; Absconded; Change of antibiotic for new disease or blood culture result; Death | 35% |
Asghar et al. 2008 (12) (SPEAR study) |
2-59 months; International; Inpatient; Very severe pneumonia | 958 | At day 5, persistent or new: Inability to drink, tachypnoea, reduced conscious level, meningitis, empyema, renal failure, septic shock; Serious adverse drug reaction; Change of antibiotic treatment; Abscondment; Death | 13.5% |
Hazir et al 2008(15) |
3-59 months; Inpatient versus outpatient; Severe pneumonia | 2037 | At day 3: Clinical deterioration; Persistence of fever with lower chest indrawing; Hospitalisation of outpatient; Development of comorbid condition requiring antibiotic; Abscondment; Death | 8% |
Addo Yobo et al. 2011(32) |
2-59 months, multi-national; Severe pneumonia | 823 | At 72 hours, persistence of fever and lower chest indrawing. Or, at day 6, clinical deterioration; Inability to take oral medication because of persisting vomiting; serious adverse event related to amoxicillin; developing a co-morbid condition; either fever or lower chest indrawing; new chest indrawing or fast breathing | 9.2% |